Recent Articles

Market Recap

While domestic and geopolitical concerns continued to make daily headlines, the major stock market indices experienced another positive quarter. The 3rd quarter extended the upward momentum, allowing equity investors to continue enjoying solid returns for 2017.
Political stories dominated the headlines during the 2nd quarter, but investors were the beneficiaries of another set of solid gains for the major market indices although the ride was somewhat bumpy. Stocks were strengthened by good corporate earnings, the prospect of possible tax cuts, and strong economic numbers in the foreign markets. This extended gains from the 1st quarter, with the Dow’s YTD change at 8.03% closing at 21,350. The S&P YTD change through 6/30/17 was 8.24% closing at 2,423 while the NASDAQ was up 14.07% closing at 6,140 for the same time period.

Investing & Economic Commentary

We recently added Huntsman Corporation (HUN) to portfolios at what we believe to be a bargain price at just ~7.0x next twelve months expected earnings. As a matter of background, Huntsman is a global manufacturer of chemical products.
Last week, we added Allergan (AGN) to portfolios, which we view as an inexpensive stock offering an attractive risk/reward profile for patient investors. As a matter of quick background, Allergan is a global pharmaceutical company that focuses on four therapeutic areas, including medical aesthetics, eye care, the central nervous system, and gastroenterology.

Financial Planning

“We become what we think about.” – Earl Nightingale According to Mr. Nightingale, I must be taxes. As many of you who know me are aware, I became addicted to learning tax law in my senior year of college.
This is a letter that I composed back in 2008, and I was absolutely surprised at the positive responses received from clients. There are some new items for 2019, but I have kept the framework the same because the basics really never change. So here we go again!